Employees: 11 (2023.0)Legal category: 5485Size: PMECreation date: 2010-01-05 (16 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: NOYON (60400), Oise
PHARMACIE M. DAMIENS : revenue, balance sheet and financial ratios
PHARMACIE M. DAMIENS is a French company
founded 16 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in NOYON (60400),
this company of category PME
shows in 2022 a revenue of 4.3 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE M. DAMIENS (SIREN 519350672)
Indicator
2025
2024
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
4 295 895 €
3 536 745 €
3 301 096 €
3 087 935 €
2 831 520 €
2 788 797 €
Net income
354 973 €
267 262 €
572 688 €
302 215 €
280 797 €
296 806 €
251 107 €
296 886 €
EBITDA
N/C
N/C
820 738 €
453 785 €
422 332 €
425 076 €
395 657 €
470 224 €
Net margin
N/C
N/C
13.3%
8.5%
8.5%
9.6%
8.9%
10.6%
Revenue and income statement
In 2025, PHARMACIE M. DAMIENS generates positive net income of 355 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 297 k€ -> 355 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
354 973 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 37%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 61%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
36.801%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
60.767%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE M. DAMIENS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2024
2025
Debt ratio
57.45
46.673
38.543
21.669
12.521
4.74
12.683
36.801
Financial autonomy
57.795
62.402
64.842
73.006
77.156
82.745
78.333
60.767
Repayment capacity
2.641
2.54
1.961
1.253
0.73
0.186
None
None
Cash flow / Revenue
11.371%
9.661%
10.093%
9.384%
9.528%
14.18%
None%
None%
Sector positioning
Debt ratio
36.82025
2022
2024
2025
Q1: 13.71
Med: 49.76
Q3: 129.07
Good+16 pts over 3 years
In 2025, the debt ratio of PHARMACIE M. DAMIENS (36.80) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
60.77%2025
2022
2024
2025
Q1: 33.42%
Med: 53.71%
Q3: 72.08%
Good-17 pts over 3 years
In 2025, the financial autonomy of PHARMACIE M. DAMIENS (60.8%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Repayment capacity
0.19 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Excellent
In 2022, the repayment capacity of PHARMACIE M. DAMIENS (0.19) ranks in the bottom 25% of the sector, which is positive. This ratio indicates the number of years needed to repay debt with cash flow. A short capacity reflects controlled debt and good cash generation.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 218.04. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
218.044
Liquidity indicators evolution PHARMACIE M. DAMIENS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2024
2025
Liquidity ratio
346.724
328.811
297.997
270.738
258.986
317.594
312.593
218.044
Interest coverage
3.425
2.44
1.789
1.309
0.754
0.162
None
None
Sector positioning
Liquidity ratio
218.042025
2022
2024
2025
Q1: 131.03
Med: 182.29
Q3: 258.7
Good-13 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE M. DAMIENS (218.04) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Interest coverage
0.16x2022
2022
Q1: 0.75x
Med: 2.51x
Q3: 5.16x
Average
In 2022, the interest coverage of PHARMACIE M. DAMIENS (0.2x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2025)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2025)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2025)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2025)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE M. DAMIENS
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2024
2025
Operating WCR
455 662 €
430 986 €
407 391 €
390 586 €
449 803 €
521 522 €
0 €
0 €
Inventory turnover (days)
33
33
34
36
37
33
0
0
Customer payment term (days)
6
5
6
6
9
8
183
0
Supplier payment term (days)
25
26
26
28
31
27
436
0
Positioning of PHARMACIE M. DAMIENS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE M. DAMIENS is estimated at
5 638 788 €
(range 3 826 508€ - 8 848 035€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
3826k€5638k€8848k€
5 638 788 €Range: 3 826 508€ - 8 848 035€
NAF 5 année 2025
Valuation method used
Net Income Multiple
354 973 €
×
15.9x
=5 638 788 €
Range: 3 826 508€ - 8 848 035€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE M. DAMIENS with other companies in the same sector:
Frequently asked questions about PHARMACIE M. DAMIENS
What is the revenue of PHARMACIE M. DAMIENS ?
The revenue of PHARMACIE M. DAMIENS in 2022 is 4.3 M€.
Is PHARMACIE M. DAMIENS profitable?
Yes, PHARMACIE M. DAMIENS generated a net profit of 355 k€ in 2025.
Where is the headquarters of PHARMACIE M. DAMIENS ?
The headquarters of PHARMACIE M. DAMIENS is located in NOYON (60400), in the department Oise.
Where to find the tax return of PHARMACIE M. DAMIENS ?
The tax return of PHARMACIE M. DAMIENS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE M. DAMIENS operate?
PHARMACIE M. DAMIENS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart